Johnson & Johnson Innovation - JJDC Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 12

Professionals
  • Investments
  • 412

  • Portfolio
  • 98

  • Exits
  • 179

Exits

Johnson & Johnson Innovation - JJDC General Information

Description

Founded in 1973, Johnson & Johnson Innovation-JJDC is the corporate venture capital arm of Johnson & Johnson and it is based in New Brunswick, New Jersey. The firm seeks to invest in seed-level startups to series B and beyond companies operating in the pharmaceuticals, medical devices, and consumer healthcare sectors.

Contact Information

Formerly Known As
Johnson & Johnson Development Corporation
Year Founded
1973
Investor Status
Actively Seeking New Investments
Trade Association
New England Venture Capital Association (NEVCA)
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • 410 George Street
  • New Brunswick, NJ 08901
  • United States
+1 (732) 000-0000

Johnson & Johnson Innovation - JJDC Investments & Acquisitions (412)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
GI Windows 29-Jun-2022 Later Stage VC 000.00 Surgical Devices Clinical Trials - General 00000 0000000000 00.0
00000000 000000000 22-Jun-2022 00000 00000 00.00 Drug Discovery Startup
0000 0000 13-Jun-2022 00000 00000 00.000 Information Services (B2C) Generating Revenue 00000 00000
0000 00000000 07-Jun-2022 00000 00000 000.00 Surgical Devices Generating Revenue
0000000000 20-May-2022 00000 00000 Practice Management (Healthcare) Startup
00000 00000000000 18-May-2022 00000 00000 0000 Drug Delivery Generating Revenue
0000000 08-Mar-2022 00000 00000 0000 Drug Discovery Startup 000000 000000 00
000000000 0000000 01-Mar-2022 00000 00000 0000 Biotechnology Generating Revenue
Rondo Therapeutics 22-Feb-2022 Early Stage VC 0000 Biotechnology Generating Revenue
Iterative Scopes 19-Jan-2022 Later Stage VC 00000 Other Healthcare Technology Systems Generating Revenue
You’re viewing 10 of 412 investments and acquisitions. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Johnson & Johnson Innovation - JJDC Exits (179)

Company Name Exit Date Exit Type Exit Size
ViaCyte 11-Jul-2022 Merger/Acquisition 00000
0000000 0000000000 25-Feb-2022 000000000000000000 000
00000.00 08-Nov-2021 000000000000000000 00000
000000000 04-Nov-2021 000000000000000000 000.00
000000000 01-Nov-2021 000000000000000000 00000
0000000000 0000000 07-Oct-2021 000000000000000000
000 000000 24-Sep-2021 000 00000
00 000000000000 24-Sep-2021 000 00 00000000
GRAIL 18-Aug-2021 Merger/Acquisition 00.00
CVRx 30-Jun-2021 IPO 00000
You’re viewing 10 of 179 exits. Get the full list »

Johnson & Johnson Innovation - JJDC Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Johnson & Johnson Innovation - JJDC Team (53)

Name Title Deals Funds Boards Office
Chris Picariello President New Brunswick, NJ
Claire Leurent Ph.D Principal, Venture Investments 0 Boston, MA
Fiona MacLaughlin Ph.D Principal, Venture Investments 0 0 London, United Kingdom
Lior Teitelbaum Principal, Venture Investments 0 0 0 New Brunswick, NJ
Wei Wu Ph.D Principal, Venture Investments 0 0 0 San Francisco, CA
You’re viewing 5 of 53 team members. Get the full list »

Johnson & Johnson Innovation - JJDC Co-Investors (447)

Name With Exits Lead Partner Series Industry
OrbiMed 11 0 0 Series chart Industry bar
Takeda Ventures 0 0 Series chart Industry bar
Alexandria Venture Investments 0 0 0 Series chart Industry bar
Osage University Partners 0 0 Series chart Industry bar
RMGLOBAL Healthcare Fund Management 0 0 Series chart Industry bar
You’re viewing 5 of 447 co-investors. Get the full list »